NTRA
HealthcareNatera, Inc.
$188.35-1.96 (-1.03%)
Prev Close
$190.31
Open
$191.38
High
$192.36
Low
$187.15
Volume
894.2K
Market Cap
$26.97B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Natera, Inc. (NTRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 154 insider sales totaling $312.59M. The most recent insider transaction was by Brophy Michael Burkes (officer: CHIEF FINANCIAL OFFICER), who sold $160.2K worth of shares on Mar 11, 2026. Natera, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $26.97B.
Buys (12M)
0
$0.00
Sells (12M)
154
$312.59M
Net Activity
Net Seller
$312.59M
Active Insiders
12
last 12 mo
NTRA Price Chart
NTRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 785 | $204.13 | $160.2K | 63,354 |
| Mar 11, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,623 | $204.13 | $1.15M | 156,607 |
| Mar 11, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 707 | $204.13 | $144.3K | 189,199 |
| Mar 11, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 915 | $204.13 | $186.8K | 150,882 |
| Mar 11, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,745 | $204.13 | $356.2K | 233,285 |
| Mar 11, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 127 | $204.13 | $25.9K | 262,325 |
| Mar 10, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,398 | $196.08 | $1.65M | 241,283 |
| Mar 3, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 7,900 | $200.02 | $1.58M | 159,435 |
| Mar 3, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 6,000 | $199.85 | $1.20M | 152,092 |
| Mar 3, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,040 | $200.19 | $1.21M | 264,794 |
| Feb 4, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 57,791 |
| Feb 4, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 206,549 |
| Feb 4, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 180,496 |
| Feb 4, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 142,406 |
| Feb 4, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 223,813 |
| Feb 4, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 435 | $230.77 | $100.4K | 263,161 |
| Feb 3, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 0 |
| Feb 3, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 0 |
| Feb 3, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 0 |
| Feb 3, 2026↗ | Sheena Jonathan | Director | Sell | 435 | $230.77 | $100.4K | 0 |
| Feb 2, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 0 |
| Feb 2, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 0 |
| Jan 29, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 63,339 |
| Jan 29, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 216,828 |
| Jan 29, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 176,468 |
| Jan 29, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 143,686 |
| Jan 29, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 226,147 |
| Jan 29, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 482 | $239.39 | $115.4K | 263,787 |
| Jan 27, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 0 |
| Jan 27, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 0 |
| Jan 27, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 0 |
| Jan 27, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 0 |
| Jan 27, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 0 |
| Jan 27, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,822 | $242.88 | $442.5K | 22,332 |
| Jan 23, 2026↗ | Sheena Jonathan | Director | Sell | 1,500 | $243.94 | $365.9K | 0 |
| Jan 22, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 100,696 |
| Jan 22, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 219,150 |
| Jan 22, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 177,591 |
| Jan 22, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 144,992 |
| Jan 22, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 227,033 |
| Jan 22, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,144 | $234.60 | $1.44M | 267,148 |
| Jan 20, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 0 |
| Jan 20, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 0 |
| Jan 20, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 0 |
| Jan 20, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 0 |
| Jan 20, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 0 |
| Jan 20, 2026↗ | Sheena Jonathan | Director | Sell | 6,144 | $234.60 | $1.44M | 0 |
| Jan 6, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 3,848 | $229.08 | $881.5K | 138,202 |
| Jan 6, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,951 | $228.95 | $675.6K | 125,158 |
| Jan 2, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 3,848 | $229.08 | $881.5K | 0 |
| Jan 2, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,951 | $228.95 | $675.6K | 0 |
| Dec 19, 2025↗ | Sheena Jonathan | Director | Sell | 1,500 | $225.94 | $338.9K | 0 |
| Dec 15, 2025↗ | Sheena Jonathan | Director | Sell | 3,070 | $227.01 | $696.9K | 0 |
| Dec 12, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,692 | $230.76 | $1.08M | 0 |
| Dec 5, 2025↗ | Chapman Rowan E | Director | Sell | 4,366 | $243.10 | $1.06M | 0 |
| Dec 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 4,400 | $238.07 | $1.05M | 0 |
| Dec 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $238.15 | $714.5K | 0 |
| Nov 24, 2025↗ | BOTHA ROELOF | Director | Sell | 75,000 | $236.12 | $17.71M | 0 |
| Nov 20, 2025↗ | Sheena Jonathan | Director | Sell | 14,000 | $226.49 | $3.17M | 0 |
| Nov 19, 2025↗ | Baynes Roy D. | Director | Sell | 12,780 | $219.85 | $2.81M | 0 |
| Nov 7, 2025↗ | Sheena Jonathan | Director | Sell | 4,570 | $197.61 | $903.1K | 0 |
| Nov 4, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 22,900 | $200.51 | $4.59M | 0 |
| Nov 3, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 160,703 | $199.96 | $32.13M | 0 |
| Nov 3, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $198.60 | $595.8K | 0 |
| Nov 3, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 17,100 | $200.00 | $3.42M | 0 |
| Nov 3, 2025↗ | Sheena Jonathan | Director | Sell | 4,000 | $200.07 | $800.3K | 0 |
| Oct 31, 2025↗ | Marcus Gail Boxer | Director | Sell | 122 | $198.71 | $24.2K | 0 |
| Oct 31, 2025↗ | ROSENMAN HERM | Director | Sell | 48,419 | $227.42 | $11.01M | 0 |
| Oct 27, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,063 | $191.15 | $967.8K | 0 |
| Oct 27, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,015 | $191.80 | $1.15M | 0 |
| Oct 27, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,709 | $191.86 | $327.9K | 0 |
| Oct 27, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $191.86 | $423.2K | 0 |
| Oct 27, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,993 | $191.87 | $382.4K | 0 |
| Oct 27, 2025↗ | Sheena Jonathan | Director | Sell | 479 | $191.98 | $92.0K | 0 |
| Oct 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,170 | $190.30 | $413.0K | 0 |
| Oct 21, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 339 | $187.95 | $63.7K | 0 |
| Oct 21, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 292 | $187.95 | $54.9K | 0 |
| Oct 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 602 | $187.95 | $113.1K | 0 |
| Oct 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,603 | $187.95 | $301.3K | 0 |
| Oct 20, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 464 | $187.95 | $87.2K | 0 |
| Oct 20, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 10,000 | $190.00 | $1.90M | 0 |
| Oct 20, 2025↗ | Sheena Jonathan | Director | Sell | 93 | $187.95 | $17.5K | 0 |
| Oct 15, 2025↗ | Sheena Jonathan | Director | Sell | 4,570 | $176.60 | $807.0K | 0 |
| Oct 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $159.99 | $480.0K | 0 |
| Sep 29, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,491 | $162.05 | $403.7K | 0 |
| Sep 29, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 23,192 | $160.80 | $3.73M | 0 |
| Sep 29, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,364 | $162.05 | $221.0K | 0 |
| Sep 18, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 50,000 | $180.33 | $9.02M | 0 |
| Sep 17, 2025↗ | Sheena Jonathan | Director | Sell | 14,070 | $178.70 | $2.51M | 0 |
| Sep 12, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 5,000 | $170.54 | $852.7K | 0 |
| Sep 2, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,079 | $166.53 | $845.8K | 0 |
| Sep 2, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $166.62 | $499.9K | 0 |
| Aug 12, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 678 | $155.46 | $105.4K | 0 |
| Aug 12, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 875 | $155.46 | $136.0K | 0 |
| Aug 8, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $157.84 | $958.1K | 0 |
| Aug 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,807 | $132.88 | $771.7K | 0 |
| Aug 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 2,496 | $133.17 | $332.4K | 0 |
| Aug 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $132.89 | $398.7K | 0 |
| Jul 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $138.36 | $700.7K | 0 |
| Jul 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,092 | $139.81 | $851.7K | 0 |
| Jul 28, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,710 | $139.81 | $239.1K | 0 |
| Jul 28, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $139.81 | $308.4K | 0 |
| Jul 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,994 | $139.81 | $278.8K | 0 |
| Jul 28, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,718 | $139.81 | $240.2K | 0 |
| Jul 28, 2025↗ | Sheena Jonathan | Director | Sell | 479 | $139.81 | $67.0K | 0 |
| Jul 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,170 | $139.94 | $303.7K | 0 |
| Jul 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 602 | $139.29 | $83.9K | 0 |
| Jul 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,622 | $139.29 | $225.9K | 0 |
| Jul 20, 2025↗ | Sheena Jonathan | Director | Sell | 93 | $139.29 | $13.0K | 0 |
| Jul 16, 2025↗ | Sheena Jonathan | Director | Sell | 3,070 | $149.96 | $460.4K | 0 |
| Jul 2, 2025↗ | Sheena Jonathan | Director | Sell | 3,000 | $160.10 | $480.3K | 0 |
| Jul 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,343 | $166.53 | $889.8K | 0 |
| Jul 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,299 | $167.36 | $719.5K | 0 |
| Jul 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $166.77 | $500.3K | 0 |
| Jun 27, 2025↗ | Chapman Rowan E | Director | Sell | 2,750 | $166.99 | $459.2K | 0 |
| Jun 18, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 20,372 | $169.79 | $3.46M | 0 |
| Jun 16, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $165.93 | $1.01M | 0 |
| Jun 10, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $164.44 | $657.8K | 0 |
| Jun 2, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,111 | $157.10 | $960.1K | 0 |
| Jun 2, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $157.07 | $471.2K | 0 |
| May 27, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,777 | $153.50 | $272.8K | 0 |
| May 27, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,940 | $154.22 | $299.2K | 0 |
| May 15, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 54,000 | $155.26 | $8.38M | 0 |
| May 9, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $159.25 | $966.6K | 0 |
| May 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,980 | $150.10 | $1.05M | 0 |
| May 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $151.61 | $606.4K | 0 |
| May 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $150.12 | $450.4K | 0 |
| Apr 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,063 | $153.38 | $776.6K | 0 |
| Apr 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,203 | $152.18 | $944.0K | 0 |
| Apr 28, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,709 | $152.18 | $260.1K | 0 |
| Apr 28, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $152.18 | $335.7K | 0 |
| Apr 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,993 | $152.18 | $303.3K | 0 |
| Apr 28, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,718 | $152.18 | $261.4K | 0 |
| Apr 28, 2025↗ | Sheena Jonathan | Director | Sell | 439 | $152.18 | $66.8K | 0 |
| Apr 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,161 | $148.92 | $321.8K | 0 |
| Apr 21, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 343 | $145.55 | $49.9K | 0 |
| Apr 21, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 296 | $145.56 | $43.1K | 0 |
| Apr 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 610 | $145.55 | $88.8K | 0 |
| Apr 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,664 | $145.55 | $242.2K | 0 |
| Apr 20, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 470 | $145.55 | $68.4K | 0 |
| Apr 20, 2025↗ | Sheena Jonathan | Director | Sell | 86 | $145.55 | $12.5K | 0 |
| Apr 3, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $136.13 | $826.3K | 0 |
| Apr 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $140.78 | $563.1K | 0 |
| Apr 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $140.48 | $421.4K | 0 |
| Mar 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,562 | $138.41 | $354.6K | 0 |
| Mar 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 25,461 | $139.70 | $3.56M | 0 |
| Mar 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,404 | $138.41 | $194.3K | 0 |
| Mar 17, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 792 | $146.04 | $115.7K | 0 |
| Mar 17, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,702 | $146.03 | $978.7K | 0 |
| Mar 17, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 795 | $146.04 | $116.1K | 0 |
| Mar 17, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,026 | $146.04 | $149.8K | 0 |
| Mar 17, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 928 | $146.04 | $135.5K | 0 |
| Mar 17, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,127 | $146.04 | $164.6K | 0 |
| Mar 17, 2025↗ | Sheena Jonathan | Director | Sell | 5,881 | $145.62 | $856.4K | 0 |
| Mar 12, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $147.69 | $590.8K | 0 |
| Mar 12, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 50,000 | $147.71 | $7.39M | 0 |
| Mar 5, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 87,272 | $143.40 | $12.52M | 0 |
| Mar 5, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 6,000 | $143.29 | $859.7K | 0 |
| Feb 26, 2025↗ | Sheena Jonathan | Director | Sell | 5,700 | $160.50 | $914.9K | 0 |
NTRA Insider Buying Activity
The following table shows recent insider purchases of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
No insider buying activity found for NTRA in the last 12 months.
NTRA Insider Selling Activity
The following table shows recent insider sales of Natera, Inc. (NTRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 785 | $204.13 | $160.2K | 63,354 |
| Mar 11, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,623 | $204.13 | $1.15M | 156,607 |
| Mar 11, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 707 | $204.13 | $144.3K | 189,199 |
| Mar 11, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 915 | $204.13 | $186.8K | 150,882 |
| Mar 11, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,745 | $204.13 | $356.2K | 233,285 |
| Mar 11, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 127 | $204.13 | $25.9K | 262,325 |
| Mar 10, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 8,398 | $196.08 | $1.65M | 241,283 |
| Mar 3, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 7,900 | $200.02 | $1.58M | 159,435 |
| Mar 3, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 6,000 | $199.85 | $1.20M | 152,092 |
| Mar 3, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,040 | $200.19 | $1.21M | 264,794 |
| Feb 4, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 57,791 |
| Feb 4, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 206,549 |
| Feb 4, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 180,496 |
| Feb 4, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 142,406 |
| Feb 4, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 223,813 |
| Feb 4, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 435 | $230.77 | $100.4K | 263,161 |
| Feb 3, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 6,939 | $227.83 | $1.58M | 0 |
| Feb 3, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 3,594 | $231.02 | $830.3K | 0 |
| Feb 3, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,334 | $230.77 | $307.8K | 0 |
| Feb 3, 2026↗ | Sheena Jonathan | Director | Sell | 435 | $230.77 | $100.4K | 0 |
| Feb 2, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 90,024 | $230.72 | $20.77M | 0 |
| Feb 2, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,639 | $231.20 | $1.07M | 0 |
| Jan 29, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 63,339 |
| Jan 29, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 216,828 |
| Jan 29, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 176,468 |
| Jan 29, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 143,686 |
| Jan 29, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 226,147 |
| Jan 29, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 482 | $239.39 | $115.4K | 263,787 |
| Jan 27, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $235.38 | $1.19M | 0 |
| Jan 27, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,970 | $238.78 | $1.43M | 0 |
| Jan 27, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,712 | $238.98 | $409.1K | 0 |
| Jan 27, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,213 | $238.98 | $528.9K | 0 |
| Jan 27, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,886 | $239.01 | $450.8K | 0 |
| Jan 27, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 1,822 | $242.88 | $442.5K | 22,332 |
| Jan 23, 2026↗ | Sheena Jonathan | Director | Sell | 1,500 | $243.94 | $365.9K | 0 |
| Jan 22, 2026↗ | Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 100,696 |
| Jan 22, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 219,150 |
| Jan 22, 2026↗ | Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 177,591 |
| Jan 22, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 144,992 |
| Jan 22, 2026↗ | RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 227,033 |
| Jan 22, 2026↗ | Sheena Jonathan | director, other: CO-FOUNDER | Sell | 6,144 | $234.60 | $1.44M | 267,148 |
| Jan 20, 2026↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 61,123 | $239.49 | $14.64M | 0 |
| Jan 20, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 73,522 | $234.74 | $17.26M | 0 |
| Jan 20, 2026↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 18,145 | $234.74 | $4.26M | 0 |
| Jan 20, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 23,498 | $234.74 | $5.52M | 0 |
| Jan 20, 2026↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 19,672 | $234.74 | $4.62M | 0 |
| Jan 20, 2026↗ | Sheena Jonathan | Director | Sell | 6,144 | $234.60 | $1.44M | 0 |
| Jan 6, 2026↗ | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | Sell | 3,848 | $229.08 | $881.5K | 138,202 |
| Jan 6, 2026↗ | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,951 | $228.95 | $675.6K | 125,158 |
| Jan 2, 2026↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 3,848 | $229.08 | $881.5K | 0 |
| Jan 2, 2026↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,951 | $228.95 | $675.6K | 0 |
| Dec 19, 2025↗ | Sheena Jonathan | Director | Sell | 1,500 | $225.94 | $338.9K | 0 |
| Dec 15, 2025↗ | Sheena Jonathan | Director | Sell | 3,070 | $227.01 | $696.9K | 0 |
| Dec 12, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 4,692 | $230.76 | $1.08M | 0 |
| Dec 5, 2025↗ | Chapman Rowan E | Director | Sell | 4,366 | $243.10 | $1.06M | 0 |
| Dec 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 4,400 | $238.07 | $1.05M | 0 |
| Dec 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $238.15 | $714.5K | 0 |
| Nov 24, 2025↗ | BOTHA ROELOF | Director | Sell | 75,000 | $236.12 | $17.71M | 0 |
| Nov 20, 2025↗ | Sheena Jonathan | Director | Sell | 14,000 | $226.49 | $3.17M | 0 |
| Nov 19, 2025↗ | Baynes Roy D. | Director | Sell | 12,780 | $219.85 | $2.81M | 0 |
| Nov 7, 2025↗ | Sheena Jonathan | Director | Sell | 4,570 | $197.61 | $903.1K | 0 |
| Nov 4, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 22,900 | $200.51 | $4.59M | 0 |
| Nov 3, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 160,703 | $199.96 | $32.13M | 0 |
| Nov 3, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $198.60 | $595.8K | 0 |
| Nov 3, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 17,100 | $200.00 | $3.42M | 0 |
| Nov 3, 2025↗ | Sheena Jonathan | Director | Sell | 4,000 | $200.07 | $800.3K | 0 |
| Oct 31, 2025↗ | Marcus Gail Boxer | Director | Sell | 122 | $198.71 | $24.2K | 0 |
| Oct 31, 2025↗ | ROSENMAN HERM | Director | Sell | 48,419 | $227.42 | $11.01M | 0 |
| Oct 27, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,063 | $191.15 | $967.8K | 0 |
| Oct 27, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,015 | $191.80 | $1.15M | 0 |
| Oct 27, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,709 | $191.86 | $327.9K | 0 |
| Oct 27, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $191.86 | $423.2K | 0 |
| Oct 27, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,993 | $191.87 | $382.4K | 0 |
| Oct 27, 2025↗ | Sheena Jonathan | Director | Sell | 479 | $191.98 | $92.0K | 0 |
| Oct 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,170 | $190.30 | $413.0K | 0 |
| Oct 21, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 339 | $187.95 | $63.7K | 0 |
| Oct 21, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 292 | $187.95 | $54.9K | 0 |
| Oct 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 602 | $187.95 | $113.1K | 0 |
| Oct 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,603 | $187.95 | $301.3K | 0 |
| Oct 20, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 464 | $187.95 | $87.2K | 0 |
| Oct 20, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 10,000 | $190.00 | $1.90M | 0 |
| Oct 20, 2025↗ | Sheena Jonathan | Director | Sell | 93 | $187.95 | $17.5K | 0 |
| Oct 15, 2025↗ | Sheena Jonathan | Director | Sell | 4,570 | $176.60 | $807.0K | 0 |
| Oct 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $159.99 | $480.0K | 0 |
| Sep 29, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,491 | $162.05 | $403.7K | 0 |
| Sep 29, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 23,192 | $160.80 | $3.73M | 0 |
| Sep 29, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,364 | $162.05 | $221.0K | 0 |
| Sep 18, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 50,000 | $180.33 | $9.02M | 0 |
| Sep 17, 2025↗ | Sheena Jonathan | Director | Sell | 14,070 | $178.70 | $2.51M | 0 |
| Sep 12, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 5,000 | $170.54 | $852.7K | 0 |
| Sep 2, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,079 | $166.53 | $845.8K | 0 |
| Sep 2, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $166.62 | $499.9K | 0 |
| Aug 12, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 678 | $155.46 | $105.4K | 0 |
| Aug 12, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 875 | $155.46 | $136.0K | 0 |
| Aug 8, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $157.84 | $958.1K | 0 |
| Aug 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,807 | $132.88 | $771.7K | 0 |
| Aug 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 2,496 | $133.17 | $332.4K | 0 |
| Aug 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $132.89 | $398.7K | 0 |
| Jul 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,064 | $138.36 | $700.7K | 0 |
| Jul 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,092 | $139.81 | $851.7K | 0 |
| Jul 28, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,710 | $139.81 | $239.1K | 0 |
| Jul 28, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $139.81 | $308.4K | 0 |
| Jul 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,994 | $139.81 | $278.8K | 0 |
| Jul 28, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,718 | $139.81 | $240.2K | 0 |
| Jul 28, 2025↗ | Sheena Jonathan | Director | Sell | 479 | $139.81 | $67.0K | 0 |
| Jul 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,170 | $139.94 | $303.7K | 0 |
| Jul 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 602 | $139.29 | $83.9K | 0 |
| Jul 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,622 | $139.29 | $225.9K | 0 |
| Jul 20, 2025↗ | Sheena Jonathan | Director | Sell | 93 | $139.29 | $13.0K | 0 |
| Jul 16, 2025↗ | Sheena Jonathan | Director | Sell | 3,070 | $149.96 | $460.4K | 0 |
| Jul 2, 2025↗ | Sheena Jonathan | Director | Sell | 3,000 | $160.10 | $480.3K | 0 |
| Jul 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 5,343 | $166.53 | $889.8K | 0 |
| Jul 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,299 | $167.36 | $719.5K | 0 |
| Jul 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $166.77 | $500.3K | 0 |
| Jun 27, 2025↗ | Chapman Rowan E | Director | Sell | 2,750 | $166.99 | $459.2K | 0 |
| Jun 18, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 20,372 | $169.79 | $3.46M | 0 |
| Jun 16, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $165.93 | $1.01M | 0 |
| Jun 10, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $164.44 | $657.8K | 0 |
| Jun 2, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,111 | $157.10 | $960.1K | 0 |
| Jun 2, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $157.07 | $471.2K | 0 |
| May 27, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,777 | $153.50 | $272.8K | 0 |
| May 27, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,940 | $154.22 | $299.2K | 0 |
| May 15, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 54,000 | $155.26 | $8.38M | 0 |
| May 9, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $159.25 | $966.6K | 0 |
| May 1, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,980 | $150.10 | $1.05M | 0 |
| May 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $151.61 | $606.4K | 0 |
| May 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $150.12 | $450.4K | 0 |
| Apr 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 5,063 | $153.38 | $776.6K | 0 |
| Apr 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,203 | $152.18 | $944.0K | 0 |
| Apr 28, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 1,709 | $152.18 | $260.1K | 0 |
| Apr 28, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,206 | $152.18 | $335.7K | 0 |
| Apr 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,993 | $152.18 | $303.3K | 0 |
| Apr 28, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,718 | $152.18 | $261.4K | 0 |
| Apr 28, 2025↗ | Sheena Jonathan | Director | Sell | 439 | $152.18 | $66.8K | 0 |
| Apr 22, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,161 | $148.92 | $321.8K | 0 |
| Apr 21, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 343 | $145.55 | $49.9K | 0 |
| Apr 21, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 296 | $145.56 | $43.1K | 0 |
| Apr 20, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 610 | $145.55 | $88.8K | 0 |
| Apr 20, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,664 | $145.55 | $242.2K | 0 |
| Apr 20, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 470 | $145.55 | $68.4K | 0 |
| Apr 20, 2025↗ | Sheena Jonathan | Director | Sell | 86 | $145.55 | $12.5K | 0 |
| Apr 3, 2025↗ | Sheena Jonathan | Director | Sell | 6,070 | $136.13 | $826.3K | 0 |
| Apr 1, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $140.78 | $563.1K | 0 |
| Apr 1, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 3,000 | $140.48 | $421.4K | 0 |
| Mar 28, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 2,562 | $138.41 | $354.6K | 0 |
| Mar 28, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 25,461 | $139.70 | $3.56M | 0 |
| Mar 28, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,404 | $138.41 | $194.3K | 0 |
| Mar 17, 2025↗ | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 792 | $146.04 | $115.7K | 0 |
| Mar 17, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 6,702 | $146.03 | $978.7K | 0 |
| Mar 17, 2025↗ | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 795 | $146.04 | $116.1K | 0 |
| Mar 17, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,026 | $146.04 | $149.8K | 0 |
| Mar 17, 2025↗ | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 928 | $146.04 | $135.5K | 0 |
| Mar 17, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,127 | $146.04 | $164.6K | 0 |
| Mar 17, 2025↗ | Sheena Jonathan | Director | Sell | 5,881 | $145.62 | $856.4K | 0 |
| Mar 12, 2025↗ | Marcus Gail Boxer | Director | Sell | 4,000 | $147.69 | $590.8K | 0 |
| Mar 12, 2025↗ | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 50,000 | $147.71 | $7.39M | 0 |
| Mar 5, 2025↗ | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 87,272 | $143.40 | $12.52M | 0 |
| Mar 5, 2025↗ | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 6,000 | $143.29 | $859.7K | 0 |
| Feb 26, 2025↗ | Sheena Jonathan | Director | Sell | 5,700 | $160.50 | $914.9K | 0 |
NTRA Insiders
Similar Stocks to NTRA
TMO
Thermo Fisher Scientific Inc.
$466.50-1.97%
$176.79B
DHR
Danaher Corporation
$186.78+0.28%
$131.71B
IDXX
IDEXX Laboratories, Inc.
$573.03+0.32%
$45.61B
IQV
IQVIA Holdings Inc.
$164.75+1.16%
$27.65B
MTD
Mettler-Toledo International Inc.
$1176.04+0.69%
$23.86B
DGX
Quest Diagnostics Incorporated
$199.39-0.74%
$23.26B
EXAS
Exact Sciences Corporation
$103.58+0.30%
$19.77B
WAT
Waters Corporation
$285.96+0.93%
$19.48B